Polygenic risk prediction: why and when out-of-sample prediction R2 can exceed SNP-based heritability

Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium

Résultat de rechercheexamen par les pairs

5 Citations (Scopus)

Résumé

In polygenic score (PGS) analysis, the coefficient of determination (R2) is a key statistic to evaluate efficacy. R2 is the proportion of phenotypic variance explained by the PGS, calculated in a cohort that is independent of the genome-wide association study (GWAS) that provided estimates of allelic effect sizes. The SNP-based heritability (hSNP2, the proportion of total phenotypic variances attributable to all common SNPs) is the theoretical upper limit of the out-of-sample prediction R2. However, in real data analyses R2 has been reported to exceed hSNP2, which occurs in parallel with the observation that hSNP2 estimates tend to decline as the number of cohorts being meta-analyzed increases. Here, we quantify why and when these observations are expected. Using theory and simulation, we show that if heterogeneities in cohort-specific hSNP2 exist, or if genetic correlations between cohorts are less than one, hSNP2 estimates can decrease as the number of cohorts being meta-analyzed increases. We derive conditions when the out-of-sample prediction R2 will be greater than hSNP2 and show the validity of our derivations with real data from a binary trait (major depression) and a continuous trait (educational attainment). Our research calls for a better approach to integrating information from multiple cohorts to address issues of between-cohort heterogeneity.

Langue d'origineEnglish
Pages (de-à)1207-1215
Nombre de pages9
JournalAmerican Journal of Human Genetics
Volume110
Numéro de publication7
DOI
Statut de publicationPublished - juill. 6 2023

Financement

We acknowledge funding from the Australian National Health & Medical Research Council ( 1173790 , 1113400 ), Australian Research Council ( FL180100072 ), and the National Institute of Mental Health ( R01MH124871 , R01MH121545 ). This work would not have been possible without the contributions of the investigators who comprise the PGC-MDD working group. The procedures followed in the PGC-MDD working group were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and that proper informed consent was obtained. Data analysis was conducted under the University of Queensland Human Research Ethics Committee approval HE002938 . For a full list of acknowledgments and ethical statements of all individual cohorts, please see the original publications. The PGC has received major funding from the US National Institute of Mental Health and the US National Institute on Drug Abuse ( U01 MH109528 and U01 MH1095320 ). Some statistical analyses were carried out on the NL Genetic Cluster Computer ( http://www.geneticcluster.org/ ) hosted by SURFsara who support the PGC through grants to Danielle Posthuma. GWAS summary statistics from 23andMe were included in the meta-analyzed GWAS summary statistics. We thank the customers, research participants, and employees of 23andMe for making this work possible. The study protocol used by 23andMe was approved by an external AAHRPP-accredited institutional review board. The graphical abstract was created with BioRender.com . We acknowledge funding from the Australian National Health & Medical Research Council (1173790, 1113400), Australian Research Council (FL180100072), and the National Institute of Mental Health (R01MH124871, R01MH121545). This work would not have been possible without the contributions of the investigators who comprise the PGC-MDD working group. The procedures followed in the PGC-MDD working group were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and that proper informed consent was obtained. Data analysis was conducted under the University of Queensland Human Research Ethics Committee approval HE002938. For a full list of acknowledgments and ethical statements of all individual cohorts, please see the original publications. The PGC has received major funding from the US National Institute of Mental Health and the US National Institute on Drug Abuse (U01 MH109528 and U01 MH1095320). Some statistical analyses were carried out on the NL Genetic Cluster Computer (http://www.geneticcluster.org/) hosted by SURFsara who support the PGC through grants to Danielle Posthuma. GWAS summary statistics from 23andMe were included in the meta-analyzed GWAS summary statistics. We thank the customers, research participants, and employees of 23andMe for making this work possible. The study protocol used by 23andMe was approved by an external AAHRPP-accredited institutional review board. The graphical abstract was created with BioRender.com. Study motivation, N.R.W. A.M.McI.; theory, X.W. P.M.V. N.R.W.; simulations & analyses, X.W.; data preparation, A.W. J.A.R. G.N. M.J.A.; first draft, X.W. N.R.W. P.M.V.; final draft, all authors read and approved the manuscript. The authors declare no competing interests.

Bailleurs de fondsNuméro du bailleur de fonds
National Institute of Mental HealthR01MH121545, R01MH124871, HE002938
National Institute on Drug AbuseU01 MH1095320, U01 MH109528
Pennsylvania Game Commission
Australian Research CouncilFL180100072
National Health and Medical Research Council1113400, 1173790

    ASJC Scopus Subject Areas

    • Genetics
    • Genetics(clinical)

    Empreinte numérique

    Plonger dans les sujets de recherche 'Polygenic risk prediction: why and when out-of-sample prediction R2 can exceed SNP-based heritability'. Ensemble, ils forment une empreinte numérique unique.

    Citer